162 related articles for article (PubMed ID: 20039426)
21. The JUPITER trial: How will it change clinical practice?
Watson KE
Rev Cardiovasc Med; 2009; 10(2):91-6. PubMed ID: 19593321
[TBL] [Abstract][Full Text] [Related]
22. Statin therapy in patients with type 2 diabetes.
Lo V; Noviasky J; Nashelsky J
Am Fam Physician; 2005 Sep; 72(5):866-8. PubMed ID: 16156346
[No Abstract] [Full Text] [Related]
23. Statins and rheumatoid arthritis.
Bhatia GS; Sosin MD; Connolly DL; Davis RC
Lancet; 2004 Nov 20-26; 364(9448):1853; author reply 1855. PubMed ID: 15555660
[No Abstract] [Full Text] [Related]
24. [JUPITER no support of changed guidelines for cardiovascular prevention. Moderate absolute risk reduction and uncertain long term effects].
Håkansson J
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1460-1. PubMed ID: 19579433
[No Abstract] [Full Text] [Related]
25. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
Olsson AG
Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
[No Abstract] [Full Text] [Related]
26. The editor's roundtable: the JUPITER trial--initial results and clinical implications.
Ridker PM; Friedewald VE; Davidson MH; Willerson JT; Roberts WC
Am J Cardiol; 2009 May; 103(10):1417-25. PubMed ID: 19427439
[No Abstract] [Full Text] [Related]
27. Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial.
Ridker PM;
Circulation; 2003 Nov; 108(19):2292-7. PubMed ID: 14609996
[No Abstract] [Full Text] [Related]
28. From here to JUPITER: identifying new patients for statin therapy using data from the 1999-2004 National Health and Nutrition Examination Survey.
Spatz ES; Canavan ME; Desai MM
Circ Cardiovasc Qual Outcomes; 2009 Jan; 2(1):41-8. PubMed ID: 20031811
[TBL] [Abstract][Full Text] [Related]
29. Can statins help healthy people?
Johns Hopkins Med Lett Health After 50; 2009 Mar; 21(1):1. PubMed ID: 19370796
[No Abstract] [Full Text] [Related]
30. The role of C-reactive protein (CRP) and statin treatment in reducing cardiovascular risk.
Chin J
S D Med; 2009 Mar; 62(3):104-6. PubMed ID: 19480274
[No Abstract] [Full Text] [Related]
31. Rosuvastatin in patients with elevated C-reactive protein.
Jenny-Avital ER
N Engl J Med; 2009 Mar; 360(10):1039; author reply 1041-2. PubMed ID: 19271275
[No Abstract] [Full Text] [Related]
32. Predicting risk and treatment benefit in atherosclerosis: the role of C-reactive protein.
Koenig W
Int J Cardiol; 2005 Feb; 98(2):199-206. PubMed ID: 15686768
[TBL] [Abstract][Full Text] [Related]
33. [Less vascular risk with rosuvastatin in elevated CRP].
Bredie B
Ned Tijdschr Geneeskd; 2009 Feb; 153(6):245. PubMed ID: 19271446
[No Abstract] [Full Text] [Related]
34. Ask the doctor. My rheumatoid arthritis gives me trouble in spite of my medications. I have read that statins, in addition to lowering cholesterol, also calm inflammation. Would taking a statin help my arthritis?
Shmerling R
Harv Heart Lett; 2006 Jan; 16(5):8. PubMed ID: 16450445
[No Abstract] [Full Text] [Related]
35. Are we lowering LDL cholesterol sufficiently?
Barter P; Rye KA
Nat Clin Pract Cardiovasc Med; 2006 Jun; 3(6):290-1. PubMed ID: 16728988
[No Abstract] [Full Text] [Related]
36. [JUPITER study about rosuvastatin and risk of cardiovascular disease. Unclear consequences for the guideline].
Lubsen J
Ned Tijdschr Geneeskd; 2009 Feb; 153(6):216-7. PubMed ID: 19271438
[No Abstract] [Full Text] [Related]
37. The biology, utilization, and attenuation of C-reactive protein in cardiovascular disease: part II.
Armani A; Becker RC
Am Heart J; 2005 Jun; 149(6):977-83. PubMed ID: 15976778
[No Abstract] [Full Text] [Related]
38. Low-risk older patients (50 years and older) with raised high-sensitivity CRP (hs-CRP) benefit from rosuvastatin therapy: the JUPITER study.
Cardiovasc J Afr; 2008; 19(6):332-4, discussion 335. PubMed ID: 19104734
[No Abstract] [Full Text] [Related]
39. Prevention of cardiovascular ischemic events: high-risk and secondary prevention.
Genest J; Pedersen TR
Circulation; 2003 Apr; 107(15):2059-65. PubMed ID: 12707251
[No Abstract] [Full Text] [Related]
40. Models for describing relations among the various statin drugs, low-density lipoprotein cholesterol lowering, pleiotropic effects, and cardiovascular risk.
Robinson JG
Am J Cardiol; 2008 Apr; 101(7):1009-15. PubMed ID: 18359323
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
